Clinical trial
Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity
NCT03232255 is registered in ClinicalTrials.gov with InQpharm Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity
- Lead sponsor
- InQpharm Group
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 25, 2017
- Completion date
- December 7, 2017
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.